Inventor

WANG ZHONGGUO

US58 patents

⚠️ This page may combine multiple inventors who share the name “WANG ZHONGGUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WANG ZHONGGUO

FORMA THERAPEUTICS INC

Activating pyruvate kinase R

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Activating pyruvate kinase R

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Inhibiting fatty acid synthase (FASN)

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Inhibiting fatty acid synthase (FASN)

FORMA TM LLC

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Amido-benzyl sulfone and sulfoxide derivates

VALO HEALTH INC

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)

FORMA TM2 INC

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

NOVO NORDISK HEALTHCARE AG

Treating sickle cell disease with a pyruvate kinase R activating compound

Activating pyruvate kinase R

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Treating sickle cell disease with a pyruvate kinase R activating compound

BAIR KENNETH W

Compounds and compositions for the inhibition of NAMPT

Compounds and compositions for the inhibition of NAMPT

Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)

VALO EARLY DISCOVERY INC

Carboxamides as ubiquitin-specific protease inhibitors

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors